Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-03 to 2024-06-04
Current total value of award: $3737.97
Description: 4565018277!OMIDRIA 1-0.3% VIAL 4ML